Patients with pulmonary fibrosis develop significant dyspnea and debilitation. Most patients demonstrate significant progression of their disease and ultimately die of respiratory failure. Current therapy for pulmonary fibrosis is largely ineffective. While the exact mechanisms of fibrosis formation are unclear, fibroblasts are thought to play a central role in fibrosis development. Fibroblasts interact with fibronectin via both alpha 4 beta 1- and alpha 5 beta 1 - integrins. Data suggests that fibronectin signals through alpha 5 beta 1 to induce a cellular invasive phenotype, and through alpha 4 beta 1 to inhibit this phenotype. Therefore, the hypothesis of this proposal is that the invasive fibroblast phenotype in human pulmonary fibrosis is regulated by an imbalance in alpha 4 and alpha 5 integrin-mediated signaling; specifically, decreased alpha 4 expression or signaling is associated with an increase in fibroblast invasion of basement membranes. In vitro and in vivo studies will be performed to address the following Specific Aims: I) to demonstrate decreased alpha 4 integrin expression relative to alpha 5 integrin expression on human fibrotic-lung fibroblasts compared to normal human lung fibroblsts and establish that increased ivasion of basement membranes correlates with decreased alpha 4 integrin expression. II) to demonstrate that the increased basement membrane invasive activity of fibrotic-lung fibroblasts results from a deficiency in intracellular PTEN activity. III) to establish that fibroblastic foci from human specimens of pulmonary fibrosis display diminished PTEN expression compared to normal human lung fibroblasts in vivo, and IV) to demonstrate that restoration of alpha 4 beta 1 and alpha 5 beta 1 integrin signaling balance in vivo by blocking fibronectin stimulated alpha 5 beta 1 integrin signaling attenuates experimental pulmonary fibrosis. Successful completion of the studies outlined in this proposal may help to define mechanisms that lead to development of pulmonary fibrosis, and may lead to the identification of more effective and specific therapies to be employed in the treatment of patients with this disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08HL070990-03
Application #
6764073
Study Section
Special Emphasis Panel (ZHL1-CSR-M (M1))
Program Officer
Colombini-Hatch, Sandra
Project Start
2002-07-01
Project End
2007-06-30
Budget Start
2004-07-01
Budget End
2005-06-30
Support Year
3
Fiscal Year
2004
Total Cost
$133,099
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Takashima, Motoki; Parsons, Christopher J; Ikejima, Kenichi et al. (2009) The tumor suppressor protein PTEN inhibits rat hepatic stellate cell activation. J Gastroenterol 44:847-55
Muro, Andres F; Moretti, Federico A; Moore, Bethany B et al. (2008) An essential role for fibronectin extra type III domain A in pulmonary fibrosis. Am J Respir Crit Care Med 177:638-45
Horowitz, Jeffrey C; Rogers, David S; Sharma, Vishal et al. (2007) Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts. Cell Signal 19:761-71
Thomas, Peedikayil E; Peters-Golden, Marc; White, Eric S et al. (2007) PGE(2) inhibition of TGF-beta1-induced myofibroblast differentiation is Smad-independent but involves cell shape and adhesion-dependent signaling. Am J Physiol Lung Cell Mol Physiol 293:L417-28
White, Eric S; Lynch 3rd, Joseph P (2007) Current and emerging strategies for the management of sarcoidosis. Expert Opin Pharmacother 8:1293-311
White, Eric S; Lynch, Joseph P (2006) Pharmacological therapy for Wegener's granulomatosis. Drugs 66:1209-28
White, Eric S; Atrasz, Rachelle G; Hu, Biao et al. (2006) Negative regulation of myofibroblast differentiation by PTEN (Phosphatase and Tensin Homolog Deleted on chromosome 10). Am J Respir Crit Care Med 173:112-21
White, Eric S; Atrasz, Rachelle G; Dickie, Emily G et al. (2005) Prostaglandin E(2) inhibits fibroblast migration by E-prostanoid 2 receptor-mediated increase in PTEN activity. Am J Respir Cell Mol Biol 32:135-41
White, Eric S; Flaherty, Kevin R; Carskadon, Shannon et al. (2003) Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis. Clin Cancer Res 9:853-60
White, Eric S; Lazar, Michael H; Thannickal, Victor J (2003) Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis. J Pathol 201:343-54

Showing the most recent 10 out of 11 publications